Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study

The number of factors initiating and stimulating the progression of breast cancer are constantly increasing. Estrogens are a risk factor for breast adenocarcinoma, the toxicity of which increases as a result of metabolism and interaction with other factors. Due to the presence of environmental expos...

Full description

Bibliographic Details
Main Authors: Ewa Sawicka, Julita Kulbacka, Małgorzata Drąg-Zalesińska, Arkadiusz Woźniak, Agnieszka Piwowar
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/6/2752
_version_ 1797609865606070272
author Ewa Sawicka
Julita Kulbacka
Małgorzata Drąg-Zalesińska
Arkadiusz Woźniak
Agnieszka Piwowar
author_facet Ewa Sawicka
Julita Kulbacka
Małgorzata Drąg-Zalesińska
Arkadiusz Woźniak
Agnieszka Piwowar
author_sort Ewa Sawicka
collection DOAJ
description The number of factors initiating and stimulating the progression of breast cancer are constantly increasing. Estrogens are a risk factor for breast adenocarcinoma, the toxicity of which increases as a result of metabolism and interaction with other factors. Due to the presence of environmental exposure to estrogens and metalloestrogens, we investigated how interactions between estrogens and toxic chromium(VI)[Cr(VI)] affect breast cancer lines and investigated whether estrogens play a protective role. The aim of the study was to investigate the effect of 17β-estradiol and its metabolites: 2-methoxyestradiol (2-MeOE2), 4-hydroxyestradiol (4-OHE2), and 16α-hydroxyestrone (16α-OHE1) in exposure to Cr(VI) on cell viability and DNA cell damage. Two estrogen-dependent breast cancer cell lines, MCF 7/WT and MDA-MB-175-VII, were examined. In addition, the expression of Cu-Zn superoxide dismutase (SOD1) was determined immunocytochemically to elucidate the mechanism of oxidative stress. The effects of single substances and their mixtures were tested in the model of simultaneous and 7-day estrogen pre-incubation. As a result, the viability of MCF-7 and MDA-MB-175-VII cells is lowered most by Cr(VI) and least by 17β-E2. In the combined action of estrogens and metalloestrogens, we observed a protective effect mainly of 17β-E2 against Cr(VI)-induced cytotoxicity. The highest expression of SOD1 was found in MCF-7/WT cells exposed to 17β-E2. Moreover, high apoptosis was caused by both Cr(VI) itself and its interaction with 4-OHE2 and 2-MeOE2. The direction and dynamics of changes in viability are consistent for both lines.
first_indexed 2024-03-11T06:07:31Z
format Article
id doaj.art-925c81c1029b434d89b9fec7315570c2
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T06:07:31Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-925c81c1029b434d89b9fec7315570c22023-11-17T12:54:43ZengMDPI AGMolecules1420-30492023-03-01286275210.3390/molecules28062752Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary StudyEwa Sawicka0Julita Kulbacka1Małgorzata Drąg-Zalesińska2Arkadiusz Woźniak3Agnieszka Piwowar4Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandDivision of Histology and Embrylogy, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, T. Chałubińskiego 6a, 50-368 Wroclaw, PolandStudents’ Scientific Society at the Department of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, PolandDepartment of Toxicology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, PolandThe number of factors initiating and stimulating the progression of breast cancer are constantly increasing. Estrogens are a risk factor for breast adenocarcinoma, the toxicity of which increases as a result of metabolism and interaction with other factors. Due to the presence of environmental exposure to estrogens and metalloestrogens, we investigated how interactions between estrogens and toxic chromium(VI)[Cr(VI)] affect breast cancer lines and investigated whether estrogens play a protective role. The aim of the study was to investigate the effect of 17β-estradiol and its metabolites: 2-methoxyestradiol (2-MeOE2), 4-hydroxyestradiol (4-OHE2), and 16α-hydroxyestrone (16α-OHE1) in exposure to Cr(VI) on cell viability and DNA cell damage. Two estrogen-dependent breast cancer cell lines, MCF 7/WT and MDA-MB-175-VII, were examined. In addition, the expression of Cu-Zn superoxide dismutase (SOD1) was determined immunocytochemically to elucidate the mechanism of oxidative stress. The effects of single substances and their mixtures were tested in the model of simultaneous and 7-day estrogen pre-incubation. As a result, the viability of MCF-7 and MDA-MB-175-VII cells is lowered most by Cr(VI) and least by 17β-E2. In the combined action of estrogens and metalloestrogens, we observed a protective effect mainly of 17β-E2 against Cr(VI)-induced cytotoxicity. The highest expression of SOD1 was found in MCF-7/WT cells exposed to 17β-E2. Moreover, high apoptosis was caused by both Cr(VI) itself and its interaction with 4-OHE2 and 2-MeOE2. The direction and dynamics of changes in viability are consistent for both lines.https://www.mdpi.com/1420-3049/28/6/275217β estradiol2-methoxyestradiol4-hydroxyestradiol16α-hydroxyestronemetalloestrogensCr(VI)
spellingShingle Ewa Sawicka
Julita Kulbacka
Małgorzata Drąg-Zalesińska
Arkadiusz Woźniak
Agnieszka Piwowar
Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
Molecules
17β estradiol
2-methoxyestradiol
4-hydroxyestradiol
16α-hydroxyestrone
metalloestrogens
Cr(VI)
title Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
title_full Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
title_fullStr Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
title_full_unstemmed Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
title_short Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
title_sort effect of interaction between chromium vi with 17β estradiol and its metabolites on breast cancer cell lines mcf 7 wt and mda mb 175 vii preliminary study
topic 17β estradiol
2-methoxyestradiol
4-hydroxyestradiol
16α-hydroxyestrone
metalloestrogens
Cr(VI)
url https://www.mdpi.com/1420-3049/28/6/2752
work_keys_str_mv AT ewasawicka effectofinteractionbetweenchromiumviwith17bestradiolanditsmetabolitesonbreastcancercelllinesmcf7wtandmdamb175viipreliminarystudy
AT julitakulbacka effectofinteractionbetweenchromiumviwith17bestradiolanditsmetabolitesonbreastcancercelllinesmcf7wtandmdamb175viipreliminarystudy
AT małgorzatadragzalesinska effectofinteractionbetweenchromiumviwith17bestradiolanditsmetabolitesonbreastcancercelllinesmcf7wtandmdamb175viipreliminarystudy
AT arkadiuszwozniak effectofinteractionbetweenchromiumviwith17bestradiolanditsmetabolitesonbreastcancercelllinesmcf7wtandmdamb175viipreliminarystudy
AT agnieszkapiwowar effectofinteractionbetweenchromiumviwith17bestradiolanditsmetabolitesonbreastcancercelllinesmcf7wtandmdamb175viipreliminarystudy